By Pushkala Aripaka (Reuters) -GSK on Tuesday agreed to buy U.S. biotech Affinivax for up to $3.3 billion, its second major deal in two months, giving the British pharmaceutical giant …
"vaccine"
-
-
(Reuters) – Danish biotechnology company Bavarian Nordic revised its annual guidance on Monday for a second time after signing supply contracts with several undisclosed countries for its Imvanex monkeypox vaccine. …
-
By Nancy Lapid (Reuters) – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has …
-
COPENHAGEN -Danish biotechnology company Bavarian Nordic on Wednesday lifted its sales outlook and now expects a smaller operating loss this year after signing a contract with an undisclosed country for …
-
WASHINGTON -U.S. health officials are in the process of releasing some Jynneos vaccine doses for use in monkeypox cases, the Centers for Disease Control and Prevention (CDC) said on Monday. …
-
WASHINGTON -The U.S. Food and Drug Administration set June 14-15 as the new meeting date to review Moderna Inc’s emergency authorization request for its COVID-19 vaccine for children aged 6 …
-
WILLIAMSPORT- The United States Attorney’s Office for the Middle District of Pennsylvania announced that Amy B. Leister, age 55, of Mifflintown, Pennsylvania, was charged on May 18, 2022, by criminal …
-
Assistant U. S. Attorney Alexandra F. Foster (619) 546-6735 NEWS RELEASE SUMMARY – May 19, 2022 SAN DIEGO – Chenyan Wu and Lianchun Chen, a married couple who worked as …
-
By Natalie Grover (Reuters) -Valneva lost nearly a fifth of its value on Monday after the French drugmaker said its COVID-19 vaccine agreement with the European Commission was likely to …
-
By SungHyuk An and Heejung Jung SEOUL – Standing tall in bright red hazmat suits, five North Korean health workers stride towards an ambulance to do battle with a COVID-19 …
-
By Josh Smith and Hyonhee Shin SEOUL – North Korea is facing its first confirmed COVID-19 outbreak with no known vaccine programme, sparking new calls for the government to accept …
-
(Reuters) – Novavax Inc’s shares plunged nearly 20% in premarket trading on Tuesday due to uncertainty over global demand for the company’s COVID-19 vaccine following a slow start to deliveries. …
-
By Promit Mukherjee and Jennifer Rigby JOHANNESBURG/LONDON -The World Health Organization (WHO) and its COVID-19 vaccine partner Gavi have no immediate plans to buy shots made by Aspen Pharmacare, the …
-
FRANKFURT -BioNTech’s first-quarter sales and earnings more than tripled thanks to demand for the COVID-19 vaccine it developed with Pfizer, but the German biotech firm is still forecasting a full-year …
-
By Michael Erman and Manas Mishra (Reuters) – COVID-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot market after delivering as many doses as …
-
By Emma Farge GENEVA -The first World Trade Organization meeting to discuss a draft agreement to temporarily waive intellectual property rights for COVID-19 vaccines went “very well”, its chair said …
-
By Nancy Lapid (Reuters) – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has …
-
TRENTON, NJ – The Republican Caucus of the New Jersey Senate on Thursday called for Governor Phil Murphy to lift the remaining mandates on public and private sector workers, including …
-
(Reuters) -The U.S. health regulator said on Thursday it was limiting the use of Johnson & Johnson’s COVID-19 vaccine for adults due to the risk of a rare blood clotting …
-
By Manas Mishra (Reuters) -Moderna Inc on Wednesday forecast higher vaccine sales for the second half of the year than in the first six months, as it expects the virus …
-
By Emma Farge GENEVA -The four main parties to negotiations on an intellectual property waiver for COVID-19 vaccines have prepared an “outcome document” for approval by the broader membership, the …
-
Biden’s DHS Isn’t Enforcing Vaccine Mandate For Illegal Immigrants: REPORT Jennie Taer on May 2, 2022 The Biden administration is releasing some migrants without COVID-19 vaccines despite a policy requiring …
-
(This May 1 story corrects variants targeted by booster shots in paragraph 8) By Doina Chiacu WASHINGTON – Moderna Inc’s chief medical officer said on Sunday the company’s vaccine for …
-
By Tim Cocks JOHANNESBURG – Africa’s first COVID-19 vaccination plant, touted last year as a trailblazer for an under-vaccinated continent frustrated by sluggish Western handouts, risks shutting down after receiving …
-
BEIJING – China’s Suzhou Abogen Biosciences Co said its COVID-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the …